penn medicine
penn surgery
penn surgery home penn surgery clinical penn surgery education penn surgery research penn surgery administration

Kim M. Olthoff, M.D., FACS
Transplant Surgery

 
  • Profile Home
  • Appointments
  • Education
  • Societies
  • Research
  • Publications
  • Awards

Administrative Office:
Hospital of the University of Pennsylvania
3400 Spruce Street
2 Dulles Building
Philadelphia, PA 19104
Administrative Assistant: Gail Cowan
Administrative Telephone: 215-662-6136
Administrative Fax: 215-622-2244
Patient Appointments: 215-662-6136
Liver Transplant Appointments:
215-662-6200

Clinical Offices:
Perelman Center for Advanced Medicine
West Pavilion, 2nd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
Clinical Telephone: 215-662-6136
Clinical Fax: 215-662-2244
Patient Appointments: 215-662-6136

Contact Information (internal use only)

kim.olthoff@uphs.upenn.edu

 

Kim M. Olthoff, MD, is the Donald Guthrie Professor of Surgery in the Division of Transplantation at Penn, Chief of the Division of Transplantation at Penn, and the Vice Chair for Faculty for Development. She attended the University of Chicago Pritzker School of Medicine, and completed a residency in general surgery at UCLA followed by a fellowship in transplantation and hepatobiliary surgery at the Dumont – UCLA Transplant Center, and joined the faculty at Penn in 1995. She is Chief of the Division of Transplant Surgery, and the Co-Director of the Transplant Center at the Children’s Hospital of Philadelphia. Dr. Olthoff’s clinical practice focuses on adult and pediatric liver transplantation, living donor transplantation, and surgery for hepatobiliary malignancies and benign liver tumors. She directs the multidisciplinary hepatobiliary tumor conference and the Liver Tumor Clinic at the Penn Transplant Institute.

Dr. Olthoff is a Past-President for the American Society of Transplant Surgery and was recently the Chair of the Liver-intestine Committee of the United Network for Organ Sharing (UNOS), the body that oversees organ allocation in the United States. She has been a board member for UNOS, Councilor for the International Pediatric Transplantation Association, and is also actively involved in the American Association for the Study of Liver Diseases. Dr. Olthoff has an active research laboratory in both basic and translational research and is a recipient of NIH funding for studies in liver regeneration, living donor transplantation, and immunologic monitoring studies in transplant recipients. She has authored or coauthored over 120 original papers and book chapters, and serves as a Deputy Editor for the journal Liver Transplantation.

 
Faculty Appointments
2011 - present Donald Guthrie Professor of Surgery
Department of Surgery
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
 
2008 - present Professor of Surgery at HUP (with tenure)
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
   
2005 - 2008 Associate Professor (with tenure)
Department of Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
2002 - 2005 Associate Professor, Department of Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
1995 - 2002 Assistant Professor, Department of Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
1993 - 1995 Clinical Instructor, Department of Surgery
UCLA School of Medicine, Department of Surgery
Los Angeles, California
 
Hospital Appointments
2013 - present Chief, Division of Transplantation Surgery
Perelman School of Medicine
Philadelphia, Pennsylvania
 
2005 - present Director, The Transplant Center
at the Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
 
2004 - present Director, Liver Transplant Program
Hospital of the University of Pennsylvania Philadelphia, Pennsylvania
 
2002 - 2004 Associate Director, Liver Transplant Program
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
1999 - present Director, Liver Transplant Program Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania
 
1995 - 2002 Assistant Director, Liver Transplant Program
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
1995 - present Attending Physician
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
Education/Training
1982 - 1986 M.D. University of Chicago
Pritzker School of Medicine, Chicago, Illinois
 
1978 - 1982 B.S. Calvin College, Grand Rapids, Michigan
(Biology/Chemistry)
 
Postgraduate Training and Fellowship Appointments
1993 - 1995 Transplant Fellow, University of California School of Medicine
The Dumont-UCLA Transplant Center
Los Angeles, California
 
1992 - 1993 Chief Resident, General Surgery
University of California School of Medicine
Los Angeles, California
 
1990 - 1992 Senior Resident, General Surgery
University of California School of Medicine
Los Angeles, California
 
1988 - 1990 Research Fellow, Department of Surgery
University of California School of Medicine
Los Angeles, California
 
1987 - 1988 Junior Resident, General Surgery
University of California School of Medicine
Los Angeles, California
 
1986 - 1987 Intern, General Surgery
University of California School of Medicine
Los Angeles, California
 
Memberships/Societies
National and International Societies
1996 - present American Society of Transplant Surgeons
President, 2012-2013
President-Elect, 2011-2012
Secretary, 2008-2011
Councilor, 2005-2008
Chair, Awards Committee, 2004-2007
Awards Committee, 1997-2000, 2004-2007
Scientific Studies Committee, 1999-2002
Program Committee, 2002-2004
 
2006 - present Scientific Registry of Transplant Recipients Technical Advisory Committee
Chair, January 2008-January 2010
Vice-Chair, January 2007-2008
 
1996 - 2007 American Society of Transplantation             
Pediatric Committee, 1996-1998
Liver-Intra-Abdominal Committee, 1997-1999, 2001-2004
Co-Chair, 2001-2003
Chair, 2003-2004
Clinical Practice Committee, 1999-2001
Education Committee, 2001-2004
 
2004 - present Association for Academic Surgery Foundation
Board member, 2004-present
Secretary/Treasurer, 2007-2011
 
1996 - present Association for Academic Surgery
Program Committee, 1996-1998
Councilor, 1999-2001
Nominating Committee, 2001, 2002, 2003
Secretary, 2001-2003
Chair, Ad Hoc AAS/SUS Relations Committee, Aug. 2002-2006
 
1999 - present The Society of University Surgeons
Representative to the National Association of Biomedical Research, 2000-2003
Ad Hoc Membership Committee, 2001
 
2008 - present American Surgical Association
 
2006 - present Society of Clinical Surgeons
 
1998 - present American Association for the Study of Liver Diseases
Practice Guidelines Committee, 2009-present
 
1998 - present The Transplantation Society
 
1999 - present American College of Surgeons (Fellow)
 
1999 - present International Pediatric Transplant Association
Development Committee, October 2002-2008
Chair, 2004-2007
Councilor, May 2002-2007
 
2000 - present  American Hepato-Pancreatico-Biliary Association
 
2002 - present United Network for Organ Sharing
Regional Councilor 2004-2007
UNOS Board Member 2004-2007
Living Donor Committee, May 2002-2005
Associate Councilor, Region 2, Dec. 2002-2004
Membership & Professional Standards Committee, Dec. 2002-2004
(Co-Chair, 2002-2004) 
Living Donor Data Task Force 2007-2009
At Large Member OPTN/UNOS Policy Oversight Comm. June 2009-June 2011
Liver and Intestine Committee, June 2009- present
Chair, 2011-2013
Vice Chair, 2009- 2011
 
2002 - present Surgical Biology Club II
 
2004 - present  American Board of Surgery
Examination Consultant, Qualifying Examination
Committee, Feb. 2004-Feb. 2007
Transplant Advisory Committee – ASTS representative
June 2010-present
 
Local Societies
  Ravdin Rhoads Society
 
  Gift of Life Donor Program Board of Directors (past)
 
  Gift of Life Donor Program Medical Advisory Committee (past)
 
  American Liver Foundation, Philadelphia Chapter, Medical Advisory Committee (past)
 
Research
Dr. Olthoff's current laboratory research involves both basic science studies and human translational research and focuses on liver regeneration in the transplant setting and ischemia/reperfusion injury as outlined below. These lines of investigation are funded by multiple NIH grants and the Biesecker Center for Pediatric Liver Disease. The research is carried out in the Stemmler laboratories, collaborative Biesecker Liver Center research space in Abramson, and with the clinical research staff on 2 Dulles. We have strong collaborations with Dr. Jason Christie (CCEB), Dr. Wayne Hancock (CHOP), and Dr. Daniel Salomon (Scripps Research Institute). The laboratory personnel have published in top-ranked journals such as Nature Medicine, Hepatology, American Journal of Transplantation, Liver Transplantation and Transplantation.
 
Animal Studies
  1. Early gene expression in the liver graft in murine models of partial hepatectomy, lobar ischemia and resection, and bile duct ligation.
    1. Use of cDNA microarray, RNA protection assays, multimeric RT-PCR technology, immunopathology, small molecule and antibody therapy.
  2. Murine whole and partial liver grafts and tolerance for ischemic injury
    1. Determining minimal liver volume and molecular events in the development of “small-for-size” syndrome.
  3. Critical factors in liver regeneration and the interplay between hepatic growth and metabolism
    1. Role of IL-6, PPAR-? signaling, and growth factors in liver regeneration in the transplant setting
Human Translational Studies
  1. Regeneration and assessment of liver function in donors and recipients following partial hepatectomy and living donor transplantation.
    1. Differential gene expression in liver biopsies and peripheral blood obtained post reperfusion, determining prognostic indicators of graft function.
    2. Utilization of other molecular techniques, such as microRNA, Luminex, and RT-PCR.
    3. Funded as part of an ancillary study to the NIH A2ALL multicenter consortium studying outcomes in living donor liver transplantation.
Clinical Research
  1. Liver regeneration after LD transplantation by volumetric imaging
  2. Impact of pretransplant locoregional therapy for HCC on post-transplant outcomes
  3. Outcome of liver transplantation in older recipients
Research Grants
NIH/NIDDK U01-DK-062494 (Olthoff, PI) 09/17/02 - 08/31/14
Adult to Adult Living Donor Liver Transplant Cohort Study (A2ALL)
Penn is one of 9 centers in this multi-center trial with the primary goal of providing information on the outcomes of adult to adult living donor liver transplantation in donors and recipients.

NIH/NIDDK RO1-DK073192 (Olthoff, PI) 07/01/06 – 6/30/09
Regeneration in the Transplant Setting: An Ancillary Study to the A2ALL
This study is within the cooperative, multi-site A2ALL consortium, examining the mechanisms occurring in the early post-transplantation period that drive molecular networks for liver regeneration and tissue repair required for graft and patient survival in living donor and deceased donor liver transplantation.

NIH/NIAID U01 A1063589 (Shaked, PI, Olthoff, Center Co-I) 09/01/04 - 08/31/11
Clinical trials in organ transplantation (CTOT-3) – Correlation of donor proinflammatory mRNA profiles with early outcomes of thoracic and abdominal transplantation
This study is a prospective observational cohort designed to test the association of proinflammatory pathways of injury in lung, heart, liver and kidney allografts with immediate and short-term function as well subsequent alloimmune response. This study will profile gene expression for the characterization of innate immunity and adaptive immunity pertinent to solid organ transplantation. Dr. Olthoff directs the liver studies

NIH/NIAID U01 AI052748 (Olthoff, Site PI) 08/15/03 - 01/31/13
Solid Organ Transplantation in HIV: Multi-Site Study
The University of Pennsylvania is one of 16 transplant centers from across the country participating in this multi-site study investigating outcomes in kidney and liver transplantation in people with HIV.

Biesecker Center for Liver Disease – Private Grant
Models of liver regeneration and ischemia/reperfusion injury in the transplant setting
This privately funded research grant provides support for the murine studies investigating the roles of growth factors and metabolic pathways in liver regeneration.

 
Publications
Research Publications, Peer Reviewed
  1. Olthoff KM, Millis JM, Imagawa DK, Nuesse BJ, Derus LJ, Rosenthal JT, Milewicz AL, Busuttil RW:  Comparison of University of Wisconsin solution vs. EuroCollins solution for the cold preservation of human liver grafts.  Transplantation 1990; 49: 284-290.
  2. Imagawa DK, Millis JM, Olthoff KM, et al:  Anti-tumor necrosis factor antibody therapy enhances allograft survival in rats.  J Surg Res  1990; 48: 345
  3. Baquerizo A, Kamada N, Millis JM. Hart J, Pera C, Orloff M, Iwaki Y, Olthoff KM, Busuttil RW.  Influence of number and timing of serum transfusions on liver allograft survival.  Trans Proc  1990; 22: 2020.Teramoto K, Baquerizo A, Imagawa DK, Olthoff KM, Dempsey RA, Busuttil RW.  Prolongation of Hepatic Allograft Survival in Rat Recipients treated with Anti-Lymphotoxin Antibody.  Trans Proc  1990; 23: 602.
  4. Imagawa DK, Millis JM, Olthoff KM, Derus LJ, Chia D, Sugich LR, Ozawa M, Dempsey RA, Iwaki Y, Levy PJ, Busuttil RW:  The role of tumor necrosis factor in allograft rejection:  I. Elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation.  Transplantation  1990; 50:219.
  5. Imagawa DK, Millis JM, Olthoff KM, Seu P, Dempsey RA, Hart J, Terasaki PI, Busuttil RW.   The role of tumor necrosis factor in allograft rejection:  II. Antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats.  Transplantation  1990; 50: 189.
  6. Seu P, Imagawa DK, Olthoff KM, Millis JM, Hart J, Wasef E, Dempsey RA, Busuttil RW.  Effects of Tumor Necrosis Factor (TNF) and Immunotherapy Directed Against TNF on Rat Cardiac Transplants.  Transplant Proc  1990; 23: 233.
  7. Olthoff KM, Millis JM, Rosove MH, Goldstein LI, Ramming KP, Busuttil RW:  Is liver transplantation justified for the treatment of hepatic malignancies?  Arch Surg  1990; 125: 1261-1268.
  8. Imagawa DK, Millis JM, Seu P, Olthoff KM, Hart J, Dempsey RA, Stephens S, Busuttil RW.  The role of tumor necrosis factor in allograft rejection:  III. Anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection.  Transplantation  1991; 51: 57.
  9. Seu P, Imagawa DK, Olthoff KM, Wasef E, Dempsey RA, Busuttil RW.  Synergistic Enhancement of Rat Cardiac Allograft Survival with Monoclonal Anti-tumor Necrosis Factor Antibody and Low-dose Cyclosporine. J Surg Research 1991; 50: 520.
  10. Olthoff KM, Wasef E, Seu P, Imagawa DK, Freischlag JA, Hart J, Busuttil RW.  PGE1 Reduces Injury in Hepatic Allografts Following Preservation.  J Surg Research  1991; 50: 595.
  11. Busuttil RW, Seu P, Millis JM, Olthoff KM, Hiatt JR, Milewicz A, Neusse BJ, El-Khoury G, Raybould D, Nyerges AM, Vargas JH, McDiarmid SV, Berquist W, Harrison R, Ament ME.  Liver transplantation in children.  Ann Surg  1991; 213: 48-57.
  12. McDiarmid SV, Hall TR, Grant EG, Milewicz AL, Olthoff KM, Lois J, Vargas J, Ament ME, Busuttil RW:  Failure of duplex sonography to diagnose hepatic artery thrombosis in high risk group of pediatric liver transplant recipients. J Pediatric Surg  1991; 26: 710-713.
  13. Farmer DG, Shaked A, Colonna JO, Olthoff KM, Jurim O, Colquhoun S, Millis JM, Busuttil RW.  Radical resection combined with liver transplantation for foregut tumors.  Am Surgeon  1993; 59:806-812.
  14. Millis JM, Imagawa DK, Olthoff KM, Martin P, Gomes A, Shaked A, Yersiz H, Drazen K, Goldstein LI, Busuttil RW.  TIPS:  Impact on liver transplantation.  Trans Proc  1995; 27: 1252-1253.
  15. Olthoff KM, Rosove MH, Imagawa DK, Shackleton CR, Farmer D, Martin P, Goldstein LI, Shaked A, Busuttil RW.  Adjuvant chemotherapy improves survival following liver transplantation for hepatocellular carcinoma.  Ann Surg  1995; 221:734-743.
  16. Jurim O, Shackleton CR, McDiarmid SV, Martin P, Shaked A, Millis JM, Imagawa DK, Olthoff KM, Maxfield A, Pakrasi AL, Melinek J, Ament M, Vargas J, Goldstein LK, Busuttil RW.  Living-Donor Liver Transplantation at UCLA.  Am J Surg  1995; 169:529-532.
  17. Moldovan S, Atiya A, Adrian T, Kleinman R, Lloyd K, Olthoff KM, Imagawa D, Shevlin L, Coy D, Walsh J, Brunicardi F.  Somatostatin Inhibits B-Cell Secretion via a Subtype-2 Somatostatin Receptor in the Isolated Perfused Human Pancreas.  J of Surg Research  1995; 59:85-90.
  18. Jurim O, Csete M, Gelabert HA, Millies JM, Olthoff KM, Imagawa D, Shaked A, McDiarmid SV, Busuttil RW.  Reduced-size grafts--the solution for hepatic artery thrombosis after pediatric liver transplantation?  J Pediatric Surg. 1995; 30:53-55.
  19. Farmer DG, Shaked A, Olthoff KM, Imagawa DK, Millis JM, Busuttil RW.  Evaluation, operative management and outcome after liver transplantation in children with biliary atresia and situs inversus. Ann. Surg.  1995;  222:47:50.
  20. Drazan KE, Wu L, Olthoff KM, Jurim O, Busuttil RW, Shaked A.  Transduction of hepatic allografts achieves local levels of viral IL-10 which suppress alloreactivity in vitro.  J. Surgical Research.  1995;  59:219-223.
  21. Jurim O, Shackleton CR, , Martin P, Shaked A, Millis JM, Imagawa DK, Olthoff KM, McDiarmid SV, Maxfield A, Pakrasi AL, Melinek J, Ament M, Vargas J, , Goldstein LI, Busuttil RW.  Living donor liver transplantation at UCLA.  Am. J. Surgery.  1995;169:529-535.
  22. Shackleton C, Martin P, Melinek J, Stothers L, Millis JM, Olthoff KM, Imagawa DK, Kinkhabwala M, Rudich S, Seu P, Shaked A, McDiarmid SV, Goldstein LI, Busuttil RW. Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3 or conversion to FK506 in cyclosporine treated primary liver allograft recipients.  Transplantation.  1995;  60:554-558.
  23. Shackleton CR, Jurim O, McDiarmid SV, Martin P, Shaked A, Maxfield A, Pakrasi AL, Melinek J, Ament M, Vargas J, Millis JM, Imagawa DK, Olthoff KM, Goldstein LI, Busuttil RW.  Living donor liver transplantation:  Potential treatment of choice for pediatric recipients.  Am. J. Surgery.  1995;169:529-32.
  24. Kleinman R, Gingerich R, Ohning G, Wong H, Olthoff K, Walsh J, Brunicardi RC.  The influence of somatostatin on glucagon and pancreatic polypeptide secretion in the isolated perfused human pancreas.  Int. J. Pancreatology.  1995; 18:51-7.
  25. Drazan KE, Shaked A, Olthoff KM, Imagawa D, Jurim O, Kiai K, Shackleton C, Busuttil RW.  Etiology and management of adult hepatic artery thrombosis after orthotopic liver transplantation.  The American Surgeon. 1996; 62:237-40.
  26. Yersiz H, Shaked A, Olthoff KM, Imagawa DK, Shackleton C, Martin P, Busuttil RW. Correlation between donor age and the pattern of liver graft recovery after transplantation.  Transplantation. 1995;60:790-794.
  27. Seu P, Olthoff KM, Rudich S, Kinkhabwala M, Imagawa DK, Neelankanta G, Goldstein LI, Martin P, Shackleton CR, Shaked A, Busuttil RW.  Liver transplantation for fulminant hepatic failure in a Jehovah’s Witness.  Clin. Transplantation. 1996; 10:404-407.
  28. Drazan KE, Olthoff KM, Wu L, Xiu-Da S, Gelman A, Shaked A.  Adenovirus-mediated gene transfer in the transplant setting:  Early events after orthotopic transplantation of liver allografts expressing TGF- 1.  Transplantation. 1996; 62:1080-1084.
  29. Imagawa DK, Olthoff KM, Hasan Y, Shackleton CR, Colquhoun SD, Shaked A, Busuttil RW.  Rapid en bloc technique for pancreas-liver procurement.  Transplantation. 1996; 61:1605-1609.
  30. Seu P, Shackleton CR, Shaked A, Imagawa DK, Olthoff KM, Rudich ST, Kinkhabwala J, Busuttil RW.  Improved results of liver transplantation in patients with portal vein thrombosis.  Arch Surg. 1996;131:840-845.
  31. Seu P, Imagawa DK, Olthoff KM.  A prospective study on the reliability and cost effectiveness of preoperative ultrasound screening of the “marginal” liver donor.  Transplantation. 1996;62:129-130.
  32. Farmer DB, Shaked A, McDiarmid SV, Olthoff KM, Imagawa KD, Millis JM, Robert ME, Lewin K, Goldstein LI, Busuttil RW.  Small intestine transplantation: The University of California Los Angeles Experience.  Transplantation Proc. 1996;28:2746-7.
  33. Millis M, Melinek J, Csete M, Imagawa DK, Olthoff KM, Neelankanta G, Braunfeld MYC, Sopher MJ, Chan SM, Pregler JL, Yersiz H, Busuttil AA, Shackleton CR, Shaked A, Busuttil RW.  Randomized controlled trial to evaluate flush and reperfusion techniques in liver transplantation.  Transplantation. 1997;63(3):397-403.
  34. Shaked A, Olthoff KM, Sellers M, Chen XD, Gelman A. Tolerance to a second donor-matched allograft following local immune modulation using transfer of sequences encoding CTLA4Ig. Transplant Proc. 1997;29(1-2):1026.
  35. Sellers M, Singer A, Maller E, Olthoff K, Jacobowski D, Shaked A.  Incidence of late acute rejection and progression to chronic rejection in pediatric liver recipients.  Transplant Proc. 1997;29(1-2) 428-9.
  36. Olthoff KM, Judge TA, Gelman A, Chen XD, Hancock WW, Linsley PS, Turka LA, Shaked A.  Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and tolerance following transduction with CTLA4Ig.  Nature Med.1998;4:194-200.
  37. Marcucci L, Shaked A, Maller ES, Rand EB, Hahn ES, Higuchi NH, Barker CF, Olthoff KM.  Supraceliac aortic pseudoaneurysms following liver transplantation in infants. Transplantation 1999;68(10):1617-1619.
  38. Zamir GA, Markmann JF, Abrams J, Macatee MR, Nunes FA, Shaked A, Olthoff KM.  The fate of liver grafts declined for subjective reasons and transplanted out of a local procurement organization.  Transplantation 2000;70(8):1149-1154.
  39. Lehrer MS, Ruchelli E, Olthoff KM, Rook AH.  Successful reversal of recalcitrant hepatic allograft rejection by photopheresis.  Liver Transpl 2000;6(5):644-7.
  40. Pfau PR, Kochman ML, Lewis JD, Long WE, Lucey MR, Olthoff K, Shaked A, Ginsberg GG.  Endoscopic management of postoperative biliary complications in orthotopic liver transplantation.  Gastrointest Endosc 2000;52(1):55-63.
  41. Komisarof JA, Olthoff K, Siegelman ES, Lawton TJ, Furth EE.  Focal nodular hyperplasia contiguous with an echinococcal cyst.  Am J Gastroenterol 2000;95(4):1078-81.
  42. Debonera F, Aldeguer X, Shen S, Gelman AE, Gao F, Que X, Greenbaum LE, Furth EE, Taub R, Olthoff KM.  Activation of IL-6/STAT3 and liver regeneration following transplantation. Surg Res 2001;96:289-295.
  43. Tsai DE, Hardy CL, Tomaszewski JE, Kotloff RM, Olthoff KM, Somer BG, Schuster SJ, Porter DL, Montone KT, Stadtmauer EA.  Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder:  Analysis of prognostic variables and long-term follow-up of 42 adult patients.  Transplantation 2001;71:1076-1088.
  44. Steinman TI, Becker BN, Frost AE, Olthoff KM, Smart FW, Suki WN, Wilkinson AH.  Guidelines for the referral and management of patients eligible for solid organ transplantation.  Transplantation 2001;71:1189-1204.
  45. Zamir G, Gelman A, Debonera F, Hardwigsen J,Que X, Aldeguer X, Martin M, Shaked A, Olthoff K.  Modified AdCTLA-4 vector blocks alloimmune response in-vitro.  J Surg Res 2001; 97:155-158.
  46. Singer AL, Olthoff KM, Kim H, Rand E, Zamir G, Shaked A.  The role of plasmapheresis in the management of acute hepatic failure in the pediatric population.  Ann Surg 2001, 234: 418-424.
  47. Olthoff KM, Gelman AE, Zamir GA, Debonera F, Krasinkas AM, Shen X, Gao F, Shaked A.  Pattern of alloimmune response in second same donor allografts after induction of tolerance using CTLA4Ig.  Transplantation  2001;Dec 27:72(12):1952-6.
  48. Shiffman ML, Brown RS Jr, Olthoff KM, Everson G, Miller C, Siegler M, Hoofnagle JH.  Living donor transplantation:  Summary of a conference at the National Institutes of Health.  Liver Transplantation 2002;8(2):174-188.
  49.  Aldeguer X, Debonera F, Shaked A, Krasinkas AM, Que X, Zamir GA, Hiroyasu S, Kovalovich KK, Taub R, Olthoff KM.  IL-6 from cells of bone marrow origin is required for normal liver regeneration.  Hepatology 2002;Jan:35(1):40-8.
  50. Tsai DE, Nearey M, Hardy CL, Tomaszewski JE, Kotloff RM, Grossman RA, Olthoff KM, Stadtmauer EA, Porter DL, Schuster SJ, Luger SM, Hodinka RL.  Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients.  Am J of Transplantation, 2002;2(10):946-954.
  51. Shah JN, Haigh WG, Lee SP, Lucey MR, Brensinger C, Kochman ML, Long WB, Olthoff K, Shaked A, Ginsberg GG.  Biliary casts following adult orthotopic liver transplantation: Clinical factors, treatment, and biochemical analysis.  Am J Gastroenterol, 2003;98:1861-1867.
  52. Abt PL, Crawford MD, Desai NJ, Markmann J, Olthoff KM, Shaked A.  Liver transplantation from controlled non-heart-beating donors:  an increased incidence of biliary complications.  Transplantation 2003;75(10):1659-1663.
  53. Hagen EA, Lautenbach E, Olthoff K, Blumberg EA.  Low prevalence of colonization with vancomycin-resistant enterococcus (VRE) in patients awaiting liver transplantation.  Am J Transplant 2003;3:902-905.
  54. Debonera F, Krasinkas A, Aldequer X, Que X, Gelman A, Shaked A, Olthoff K.  Dexamethasone inhibits the early regenerative response of the rat liver after cold preservation and transplantation.  Hepatology 2003;Dec:38(6):1563-1572.
  55. Abt PL, Desai NJ, Crawford MD, Forman L, Markmann JW, Olthoff KM, Markmann JF.  Survival following liver transplantation from non-heart beating donors.  Ann Surg 2004;239:87-92.
  56. Weinrieb RM, Barnett R, Lynch KG, DePiano M, Atanda A, Olthoff KM. A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients. Liver Transpl 2004;10:97-106.
  57. Que X, Debonera F, Xie J, Furth EE, Aldeguer X, Gelman AE, Olthoff KM.  Pattern of ischemia reperfusion injury in a mouse orthotopic liver transplant model J Surg Res 2004;116:262-268.
  58. Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, Rosen M, Soulen M, Shaked A, Reddy KR, Olthoff KM. Liver transplantation for hepatocellular carcinoma: Validation of present selection criteria in predicting outcome. Liver Transpl 2004; 10(7):911-918.
  59. Velidedeoglu E, Bloom RD, Crawford MD, Desai NM, Campos L, Apt P, Markmann JW, Mange KC, Olthoff KM, Shaked A, Markmann JF.  Early kidney dysfunction post liver transplantation predicts late chronic kidney disease.  Transplantation 2004;77(4):553-556.
  60. Stewart CA, Wertheim J, Olthoff K, Furth EE, Brensinger C, Markman J, Shaked A.  Ascites after liver    transplantation – A mystery.  Liver Transpl 2004;10(5):654-660.
  61. Abt PL, Mange K, Olthoff KM, Reddy R, Shaked A.  Allograft survival following adult to adult living  donor liver transplantation.  Am J Transplant 2004;4(8):1302-7.
  62. Abt PL, Rapaport-Kelz R, Desai N, Frank A, Sonnad S, Rand E, Markmann JF, Shaked A, Olthoff KM.  Survival among pediatric liver transplant recipients:  Impact of segmental grafts.  Liver Transpl 2004;10(10):1287.
  63. Shah JN, Ahmad NA, Shetty K, Kochman ML, Long WB, Brensinger CM, Pfau PR, Olthoff K, Markmann J, Shaked, Reddy KR, Ginsberg GG.  Endoscopic management of biliary complications after adult living donor transplantation.  Am J Gastroenterol 2004;99(7):1291-5.
  64. Olthoff KM, Brown RS Jr., Delmonico FL, Freeman RB, McDiarmid SV, Merion RM, Millis JM, Roberts JP, Shaked A, Wiesner RH, Lucey MR.  Summary report of a national conference: Evolving concepts in liver allocation, the MELD and PELD era.  Liver Transpl.  2004:10 Suppl 10:A6.
  65. Makuuchi M, Miller CM, Olthoff K, Schwartz M.  Adult-adult living donor liver transplantation.  J Gastrointest Surg 2004:8(3):303-12.
  66. Hanto DW, Fishbein TM, Pinson CW, Olthoff KM, Shiffman ML, Punch JD, Goodrich NP.  Liver and intestine transplantation:  Summary Analysis, 1994-2003.  Am J Transplant 2005;5(Part 2):916-933.
  67. Debonera F, Wang G, Xie J, Gelman A, LeClair C, Xin D, Shaked A, Olthoff KM.  Severe preservation injury induces II-6/STAT3 activation with lack of cell cycle progression after partial liver graft transplantation. Am J Transplant 2004;4(12):1964-1971.
  68. Porrett PM, Desai SS, Timmins KJ, Twomey CR, Sonnad SS, Olthoff KM.  Combined orthotopic heart and liver transplantation:  The need for exception status listing.  (Liver Transpl 2004;10(12):1539-1544.
  69. Zamir G, Gelman AE, Olthoff KM, Debonera F, Aldeguer X, Shaked A.  Patterns of transgene expression and viral clearance from the transplanted liver following ex vivo adenovirus-mediated gene transfer.  Journal of Hepatology  2004;41:714-720.
  70. Campbell MS, Kotlyar DS, Brensinger CM, Lewis J, Shetty K, Bloom RD, Markmann JF, Olthoff KM, Shaked A, Reddy KR.  Renal function after orthotopic liver transplantation is predicted by duration of pre-transplantation creatinine elevation.  Liver Transpl.  2005; 11(9):1048-55.
  71. Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, Freise CE, Kam I, Pruett TL, Everhart JE, Hulbert-Shearon TE, Gillespie, BW, Edmond JC, A2ALL Study Group.  Outcomes of 385 Adult-to-Adult Living Donor Liver Transplant Recipients.  Ann Surg 2005;242(3):1-12.
  72. Tsai DE, Aqui NA, Tomaszewski JE, Olthoff KM, Ahya VN, Kotloff RM, Bloom RD, Brozena SC, Hodinka RL, Stadtmauer EA, Schuster SJ, Nasta SD, Porter DL, Luger SM, Klumpp TR.  Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder.  Clin Transplant 2005;644-652.
  73. Elstrom RL, Andreadis C, Aqui NA, Ahya VN, Bloom RD, Brozena SC, Olthoff KM, Schuster SJ, Nasta SD, Stadtmauer EA, Tsai DE.  Treatment of PTLD with rituximab or chemotherapy.  Am J Transplant  2006;6(3):569-76.
  74. Canter RJ, Abt PL, Litzky LA, Frank A, Abt AB, Sellers MT, Markmann JF, Olthoff KM, Naji A, Shaked A.  Successful liver, kidney, and pancreas transplantation from a donor with cerebral emboli from a left atrial myxoma.  Transplant Proc 2005;37(10):4334-6.
  75. Abt PL, Abdullah I, Korenda K, Frank A, Peterman H. Stephenson GR, Markmann JF, Shaked A, Olthoff KM.  Appendicitis among liver transplant rcipients.  Liver Transpl 2005;11(10):1282-4.
  76. Rand EB, Bunin N, Cochran W, Ruchelli E, Olthoff K, Bloomer JR.  Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria.  Pediatrics 2006;118(6):1894-1897.
  77. Xie JF, Wang G, Debonera F, Han R, Dorf ME, Hancock W, Olthoff KM.  Selective neutralization of the chemokine TCA3 reduces the increased injury of partial versus whole liver transplants induced by cold preservation.  Transplantation 2006 Dec 15;82(11):1501-9.
  78. Abt P, Kashyap R, Orloff M, Jain A, Tsoulfas G, Bozorgzadeh A, Olthoff K.  Pediatric liver and kidney transplantation with allografts from DCD donors:  A review of UNOS Data.  Transplantation 2006;82:1707-1710.
  79. Zamir G, Zeira E, Gelman AE, Shaked A, Olthoff KM, Eid A, Galun E.  Replication-deficient adenovirus induces host topoisomerase 1 activity:  Implications for adenovirus-mediated gene expression.  Mol Ther 2007;15:772-81.
  80. Patel H, Vogl DT, Aqui N, Shaked A, Olthoff K, Markmann J, Reddy R, Stadtmauer EA, Schuster S, Tsai DE.  Posttransplant lymphoproliferative disorder in adult liver transplant recipients:  A report of seventeen cases.  Leuk Lymphoma 2007;48(5):885-891.
  81. Fisher RA, Kulik LM, Freise CE, Lok ASF, Shearon TH, Brown Jr. RS, Ghobrial RM, Fair JH, Olthoff KM, Kam I, Berg CL, A2ALL Study Group.  Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation:  The A2ALL Study.  Am J of Transplant 2007;7:1601-1608.
  82. Fayek S, Moore D, Bortecen KH, Yeh H, Markmann JF, Olthoff KM, Shaked A.  Liver transplantation in the setting of extra-hepatic malignancy:  Two Case Report.  Transplant Proc 2007;39:3512-3514.
  83. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, Freise CE, Benet LZ, Ascher NL, Roberts JP, Murphy B, Keller MJ, Olthoff KM, Blumberg EA, Brayman KL, Bartlett ST, Davis CE, McCune JM, Bredt BM, Stablein DM, Stock PG.  HIV-Infected liver and kidney transplant recipients: 1- and 3- year outcomes.  Am J of Transplant 2008;8:355-365.
  84. Tsai DE, Douglas L, Andreadis C, Vogl DT, Arnoldi S, Kotloff R, Svoboda J, Bloom RD, Olthoff KM, Brozena SC, Schuster SJ, Stadtmauer Ea, Robertson ES, Wasik MA, Ahya VN.  EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder:  Results of a two-arm prospective trial.  Am J Transplant 2008; 2008 May;8(5):1016-24.
  85. Bahirwani R, Campbell M, Siropaides T, Markmann J, Olthoff K, Shaked A, Bloom R, Reddy R.  Transplantation:  Impact of pre-transplant renal insufficiency.  Liver Transpl  2008;14:665-71.
  86. Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, Fisher RA, Kinkhabwala MM, Koffron AJ, Pruett TL, Olthoff KM, A2ALL Study Group.  Donor morbidity after living donation for liver transplantation. Gastroenterology 2008: 135(2):468-76.
  87. Nakamoto N, Kaplan DE, Coleclough J, Li Y, Kaminski M, Shaked A, Olthoff K, Gostick E, Price DA,  Freeman GJ, Wherry EJ, Chang K-M.  Functional restoration of HCV-specific CD8 T-cells by PD1 blockage is defined by PD1 expression and compartmentalization.  Gastroenterology 2008:134(7):1927-37.
  88. Mas VR, Maluf DG, Archer KJ, Yanek K, Kong X, Kulik L, Freise CE, Olthoff KM, Ghobrial RM, Mclver P, Fisher R. Genes involved in viral carcinogenesis and tumor initiation in Hepatitis C Virus-induced Hepatocellular Carcinoma. Mol Med 2008 Dec 21.
  89. Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, Fair JH, Fisher RA, Olthoff KM, Trotter JF, Ghobrial RM, Everhart JE, A2ALL Study Group.  Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant 2008 Dec;8(12):2569-79.
  90. Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, Kaminski M, Gostick E, Price DA, Freeman GJ, Wherry EJ, Chang KM. Synertistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog.2009:Feb 5(2):e1000313.
  91. Hoffman SA, Wang L, Shah CV, Ahya VN, Pochettion A, Olthoff K, Shaked A, Wille K, Lama VN, Milstone A, Ware LB, Orens J, Weinacker A, Demissie E, Bellamy S, Kawut SM, Hancock WW, Christie JD, Lung Transplant Outcomes Group. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant 2009:Feb;9(2):359-96.
  92. DeJonge J, Kurian S, Shaked A, Reddy R, Hancock W, Salomon D, Olthoff K. Unique early gene expression patterns in human adult to adult living donor liver grafts compared to deceased donor grafts. Am J Transplant 2009 Apr;9(4):758-72.
  93. Abecassis MM, Burke R, Klintmalm GB, Matas AJ, Merion RM, Millman D, Olthoff K, Roberts JP, American Society of Transplant Surgeons. American society of transplant surgeons transplant center outcomes requirements—a threat to innovation. Am J Transplant 2009:Jun;9(6):1279-86.
  94. Marin HL, Rurth EE, Olthoff K, Shaked A, Soulen MC. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma. J Gastrointestin Liver Dis. 2009:Jun;18(2):169-76.
  95. Shiley KT, Gasink LB, Barton TD, Pfeiffenberger P, Olthoff KM, Blumberg EA. Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis. Liver Transpl. 2009:Aug;15(8):963-67.
  96. Reed Al, Merion RM, Roberts JP, Klintmalm GB, Abecassis MM, Olthoff KM, Langnas AN. The Declaration of Istanbul: Review and commentary by the American Society of Transplant Surgeons Ethics Committee and Executive Committee. Am J Transplant 2009Nov; 9(11):2466-2469.
  97. Olthoff KM, Kulik L, Samstein B, Abecassis M, Emond J, Shaked A, Christie JD. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010 Aug; 16(8):943-949.
  98. Cassuto JR, Reese PP, Sonnad S, Bloom RD, Levine MH, Olthoff KM, Shaked A, Naji A, Abt P. Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients. Am J Transplant 2010 Nov; 10(11):2502-11.
  99. Bunin N, Guzikowski V, Rand ER, Goldfarb S, Baluarte J, Meyers K, Olthoff KM. Solid organ transplants following hematopoietic stem cell transplant in children. Pediatr. Transplant 2010 Dec; 14(8):1030-5.
  100. Olthoff KM, Abecassis MM, Emond JC, Kam I, Merion RM, Gillespie BW, Tong L; and the A2ALL Study Group. Outcomes for adult living donor liver transplantation: Comparison of A2ALL and national experience. Liver Transpl. 2011 Feb 25 101. Florence LS, Feng S, Foster CE 3rd, Fryer JP, Olthoff KM, Pomfret E, Sheiner PA, Sanfey H, Bumgardner GL. Academic careers and lifestyle characteristics of 171 transplant surgeons in the ASTS. Am J Transplant 2011 Feb; 11(2):261-71.
  101. Mendizabal M, Reddy KR, Cassuto J, Olthoff KM, Faust TW, Makar GA, Rand EB, Shaked A, Abt, PL. Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing
    data. Liver Transpl. 2011 Mar: 17(3):243-50.
  102. Trotter JF, Gillespie BW, Terrault NA, Abecassis MM, Merion RM, Brown RS Jr, Olthoff KM,
    Hayashi PH, Berg CL, Fisher RA, Everhart JE; Adult-to-Adult Living Donor Liver Transplantation
    Cohort Study  Group. Laboratory test results after living donation in the adult-to-adult living donor
    liver transplantation cohort study. Liver Transpl. 2011 Apr; 17(4): 409-17.
  103. Bunchorntavakul C, Bahirwani R, Drazek D, Soulen, MC, Siegelman ES, Furth EE, Olthoff K, Shaked
    A, Reddy KR; Clinical features and natural history of hepatocellular adenomas: the impact of obesity.
    Alimentary Pharmacology and Therapeutics 2011.
  104. Olthoff KM, Abecassis MM, Emond JC, Kam I, Merion RM, Gillespie BW, Tong L; Adult-to-adult
    Living Donor Liver Transplantation Cohort Study Group. Liver Transpl. 2011 Jul; 17(7):789-97.
  105. Yoo PS, Olthoff KM, Abt PL; Donation after cardiac death in pediatric organ transplantation. Curr
    Opin Organ Transplant. 2011 Oct; 16(5):483-8.
  106. Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS Jr, Baker TB, Everson GT, Hong JC,
    Terrault N, Hayashi PH, Fisher RA, Everhart JE; Liver transplant recipient survival benefit with living
    donation in the model for endstage liver disease allocation era. Hepatology. 2011 Oct; 54(4):1313-21.
  107. Friedman BH, Wolf JH, Wang L, Putt ME, Shaked A, Christie JD, Hancock WW, Olthoff KM; Serum
    cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation. Liver Transpl. 2011 Oct 17.
  108. Abecassis MM, Fisher RA, Olthoff KM, Freise CE, Rodrigo DR, Samstein B, Kam I, Merion RM; the
    A2ALL Study Group; Complications of living donor hepatic lobectomy-a comprehensive report. Am J
    Transplant. 2012 Feb 15. PMID: 22335782.
  109. Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, Ragni MV, Barin B, Simon D,
    Olthoff KM, Johnson L, Stosor V, Jayaweera D, Fung J, Sherman KE, Subramanian A, Michael Millis
    J, Slakey D, Berg CL, Carlson L, Ferrell L, Stablein DM, Odim J, Fox L, Stock PG; for the HIV-TR
    Investigators. Outcomes of liver transplantation in HCV-HIV coinfected recipients. Liver Transpl. 2012
    Feb 12.18(6): p. 716-726. PMID: 22328294.
  110. Harbell, J., Fung, J., Nissen, N., Olthoff, K., Florman, S. S., Hanto, D. W., Light, J., Bartlett, S.
    T. , Tzakis, A. G. , Pearson, T. C. , Barin, B. , Roland, M.E. , Stock, P. G.,  Surgical Complications in
    275 HIV+ Liver and/or Kidney Transplant Recipients. Surgery, 2012; 152(3): P. 376-8.1.
  111. Aufhauser DD Jr, Rose T, Levine M, Barnett R, Ochroch EA, Aukburg S, Greenblatt E, Olthoff K,
    Shaked A, Abt P; Cardiac arrest associated with reperfusion of the liver during transplantation:
    incidence and proposal for a management algorithm. Clin Transplant. 2012 Dec 27. Doi: 10.1111/ctr.
    12052. PMID: 23278482.
  112. Cantu, E., Lederer, D.J., Meyer, K., Milewski, K., Suzuki, Y., Shah, R.J., Diamond, J.M., Meyer, N.J.,
    Tobias, J.W., Baldwin, D.A., Van Deerlin, V.M., Olthoff, K.M., Shaked, A., Christie, J.D.; Gene set
    enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung
    transplantation.   American Journal of Transplantation, 2013May 24. P. 1-7. Doi: 10.1002/ajt.12283.
Contributions to Peer-Reviewed Clinical Research Publications, Participation Cited but not by Authorship
  1. Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS Jr, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB; A2ALL Study Group. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl. 2007;13(1):122-9.
  2. Trotter JF, Wisniewski KA, Terrault NA, Everhart JE, Kinkhabwala M, Weinrieb RM, Fair JH, Fisher RA, Koffron AJ, Saab S, Merion RM; A2ALL Study Group. Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology. 2007;46(5):1476-84.
  3. Berg CL, Gillespie BW, Merion RM, Brown RS Jr, Abecassis MM, Trotter JF, Fisher RA, Freise CE, Ghobrial RM, Shaked A, Fair JH, Everhart JE; A2ALL Study Group. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology. 2007;133(6):1806-13.
  4. Campsen J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS, Saab S, Wisniewski KA, Trotter JF; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl 2008;14(9):1273-80.
  5. Northup PG, Abecassis MM, Englesbe MJ, Edmond JC, Lee VD, Stukenborg GJ, Tong L, Berg CL; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl 2009 Feb; 15(2):148-62.
Research Publications, Non-Peer-Reviewed
  1. Olthoff KM and Busuttil RW. Portal decompression vs. sclerotherapy for bleeding esophageal varices. Surg Rounds 1990; 13 (10): 33-43.
  2. Colonna JO, Olthoff KM, Seu P, Busuttil RW: Liver resections for primary neoplasms. Adv Surg 1992; 25: 309.
  3. Seu P, Winston DJ, Olthoff KM, Bruckner DA, Busuttil RW. Legionnaires' disease in liver transplant recipients. Infectious Disease in Clinical Practice 1993; 2: 109-113.
  4. Holt CD, Winston DJ, Kubak B, Imagawa DK, Martin P, Goldstein L, Olthoff KM, Millis JM, Shaked A, Shackleton CR, Busuttil RW. Coccidioidomycosis in liver transplant patients. Clin Infec Dis. 1997;24(2):216-21.
  5. McDiarmid SV, Millis MJ, Olthoff KM, So SK. Indications for pediatric liver transplantation Pediatr Transplantation 1998;2:106-116.
  6. Olthoff KM. Surgical options for hepatocellular carcinoma: Resection and transplantation. Liver Transpl Surg 1998;4:S98-S104.
  7. Olthoff KM. Molecular pathways of regeneration and repair in liver transplantation. World Journal of Surgery 26:831-837, 2002.
  8. Rand EB, Olthoff KM. Pediatric liver transplantation. Graft 6(2):145-150,2003.
  9. Rand EB, Olthoff KM. Overview of pediatric liver transplantation. Gastroenterol Clin North Am 2003;32(3):913-29.
  10. Olthoff KM. Hepatic regeneration in living donor liver transplantation. Liver Transplantation 2003;9(10):S35-S41.
  11. Olthoff KM.  The grading of donor complications: GPAs or pass/fail?  Am J Transplant 2011 Jan;11(1):
    11-2.
Abstracts
  1. Marin H, Soulen MC, Clark TW, Tuite CM, Furth EE, Olthoff K.  Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.  JVIR 2004;15(2part2):S214-5.
  2. Porrett PM, Sonnad S, Timmins K, Rosen M, Soulen M, Shaked A, Furth E, Olthoff K.  Pretransplant locoregional ablative therapy for CHH may not provide beneficial effect in the current MELD era.  Hepatology 2004;40(4):194A. Presented in “Hot topics in Hepatology” oral session at AASLD.
  3. Xie J,  Wang G, Debonera F, LeClair C, Xin D, De Jonge J, Gelman A, Shaked A, Olthoff K.  Il-6 inhibits apoptotic mechanisms and promotes graft survival after liver transplantation.  Am J Transpl 2005;5(Supp 11):432.
  4. LeClair C, Xin D, Wang GD, Xie J, Debonera F, De Jonge J, Furth E, Olthoff KM.  Insulin like growth factor-binding protein-1 is critical for glucose homeostasis and recovery after small-for-size liver transplantation.  Am J Transpl 2005;5(Supp 11):515.
  5. Rand EB, Goodsell C, Olthoff KM, Shaked A.  Sirolimus monotherapy experience in pediatric liver transplant recipients.  Am J Transpl 2005;5(Supp 11):527.
  6. Xie J, Wang G, Debonera F, LeClair C, Dong X, De Jonge J, Gelman A, Han R, Dorf ME, Shaked A, Hancock W, Olthoff KM.  ANTI-TCA-3 monoclonal antibody treatment reduces the cold preservation injury in a mouse 50% liver transplant model.  Am J Transpl 2005;5(Supp 11):566.
  7. Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair, JH, Fisher RA, Freise CE, Kam I, Pruett TL, Emond JC.  Factors associated with graft failure and outcome in 354 adult living donor liver transplants (ALDLT): a report from the A2ALL consortium.  (Presented by KM Olthoff at Plenary Session ASA 2005).
  8. Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, Fair JH, Fisher RA, Olthoff KM, Trotter JF, Ghobrial RM, A2ALL Study Group.  Comparison of complication rates in recipients of living donor and deceased donor liver transplants: findings from the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL). Hepatology 2006;44(Suppl 1):429A.
  9. Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, Fisher RA, Kinkhabwala MM, Koffron AJ, Pruett TL, Olthoff KM, A2ALL Study Group. Donor morbidity and mortality of adult living donors for liver transplantation.  Am J Transplant 2006;6(Suppl2):115.
  10. deJonge J, Kurian S, Salomon DR, Tilanus HW, vanderLan L, Olthoff K.  Gene expression profile of regeneration in human living-donor liver transplantation.  Liver Transplantation 2006;12:(5,Supp 1):C-38.
  11. Merion RM, Goodrich NP, Freeman Jr. RB, Olthoff KM, Edwards EB, Wiesner Jr. RH, McDiarmid SV.  Impact of a regional allocation rule for high MELD/PELD liver transplant candidates.  Liver Transplantation 2006;12:(5,Supp 1):C-103.
  12. Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, Fisher RA, Kinkhabwala MM, Koffron AJ, Pruett TL, Olthoff KM.  Donor morbidity and mortality of adult living donors for liver transplantation.  Am J Transpl 2006;6(Suppl 2):115.
  13. Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, Fair JH, Fisher RA, Olthoff KM, Trotter JF, Ghobrial RM, A2ALL Study Group.  Comparison of complication rates in recipients of living donor and deceased donor liver transplants:  findings from the adult-to-adult living donor liver Transplantation Cohort Study.  Hepatology 2006;44(Suppl 10:124A).
  14. Porrett P, Yeh H, Korenda K, Rivera T, Pfeiffenberger P, Shaked A, Markmann JF, Olthoff KM.  Similarity in liver transplant outcomes between older and younger adult recipients.  Am J Transpl 2006;
  15. Tsai D, Douglas L, Andreadis C, Svoboda J, Arnoldi S, Bloom R, Olthoff K, Brozena S, Schuster S, Stadtmauer S, Kotloff R, Ahya V.  Two-arm prospective trial evaluating the ability of a novel EBV PCR panel to diagnose and monitor posttransplant lymphoproliferative disorder.  Am J Transpl 2006;
  16. Abt P, Kashyap R, Orloff M, Jain A, Younan D, Maloo M, Mohanka R, Olthoff K.  Pediatric liver and kidney transplantation with allografts from DCD donors: A review of UNOS data.  Am J Transpl 2006;
  17. Debonera F, Eaton M, Xie JF, Furth E, KM Olthoff. Insulin growth factor binding protein 1 is important for normal glucose metabolism and energy output under stress. Academic Surgical Congress Phoenix AZ February 2007, J Surg Res Feb 2007; 137(2).
  18. Olthoff K, Christie J, Samstein B, Kulik L, Shaked A, Abecassis M, Emond J.  Validity of the definition of early allograft dysfunction in liver transplant recipients.  Am J Transpl 2007;7:5.
  19. Olthoff K, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J, Shaked A, Cristie J.  Risk factors for developing early allograft dysfunction following liver transplantation.  Am J Transpl 2007;7:5.
  20. Olthoff K, Kurian S, deJonge J, Shaked A, Salomon D.  Unique gene expression patterns in brain dead deceased donor liver grafts at time of procurement.  Am J Transpl 2007;7:5.
  21. Xie J, Han R, Debonera F, Hahcock W, Olthoff, K.  IP-10 is important for liver ischemia reperfusion injury but is not required for liver regeneration.  Am J Transpl 2007;7:5.
  22. Porrett PM, Siropaides T, Shaked A, Reddy R, Olthoff K.  Pretransplant treatment of HCC outside UNOS criteria results in improved post-transplant survival equivalent to HCC within criteria.  Am J Transpl 2007;7:465(2).
  23. Tsai DE, Douglas L, Andreadis C, Arnoldi S, Bloom R, Olthoff K, Brozena S, Stadtmauer EA, Kotloff R, Ahya V.  A two-arm prospective trial evaluating the ability of EBV PCR to diagnose and monitor posttransplant lymphoproliferative disorder. American Society of Clinical Oncology Programs/Proceedings 2007, Page  455s.
  24. Abecasis MM, Olthoff KM, Trotter JF, Fisher RA, Merion RM, Tong L, Samstein B, Busuttil RW, Freise CE, Hayashi PH, Berg CL, Complications after living liver donation: a prospective, multicenter report. Hepatology 2008;48(Suppl):309A.
  25. Jensen GS, Nerrault NA, Blei AT, Merion RM, Gillespie BW, Everhart JE, Brown RS, Olthoff KM, Hayashi PH, Berg CL, Fisher RA, Trotter JF.  Long-term follow-up of laboratory values in right hepatic lobe liver donors following donation: the A2All experience.  Hepatology 2008;48(Suppl): 352A.
  26. Olthoff KM, Abecassis MM, Emond JC, Merion RM, Gillespie BW, Tong L, A2All Study Group.  Comparison of A2ALL and national experience with adult-to-adult living donor liver transplantation (AALDLT) outcomes: analysis of center experience and mortality risk factors. Am J Transpl 2008;8(Suppl 2):224. (Plenary Session at ATC 2008).
  27. OlthoffKM, Emond JC, Trotter JF, Tong L. Merion RM, Baker TB, Berg CL, Fisher RA, Freise CE, Hayashi PH, Hong J, Everhart JE, A2ALL Study Group.  Liver regeneration in donors and recipients in the Adult-to-Adult Living Donor Liver Transplant Cohort Study.  Am J Transplantation 2009; 9
    (Suppl 2): 232.
  28. Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault
    N, Hayashi PH, Fisher RA, Everhart JE.  Benefit of living donor liver transplantation according to
    MELD score and diagnosis of hepatocellular carcinoma.  Hepatology 2009:50(Suppl):339A.
  29. Terrault N, Barin B, Shiano TD, Poordad F, Wong M, deVera ME, Simon D, Rosenthal L, Jayaweera D,
    Johnson LB, Olthoff KM, Stosor VS, Sherman KE, Eghtesad JP, Harland R, Regenstein F, Hamilton JP,
    Pruett TL, Roland M, Stock P.  Survival and risk of severe Hepatitis C virus (HCV) recurrence in liver
    transplant (LT) recipients coinfected with human immunodeficiency virus (HIV) and HCV.  Hepatology
    2009:50(Suppl):396A.
  30. Mendizabal M, Shaked A, Cassuto J, Reddy KR, Olthoff KM, Abt PL.  Liver transplantation in patients
    with cystic fibrosis:  an analysis of the UNOS database.  Hepatology 2009:50(Suppl):559A.
  31. Abt PL, Siddharth AP, Cassuto, J, Sonnad S, Levine M, Olthoff KM, Naji A, Shaked A, Zand M.  End- 
    stage renal disease after liver transplantation: an assessment of mortality and the benefit of kidney
    transplantation.  Am J Transplantation 2010: 10 (Suppl 4): 99.
  32. Reese, P, Bloom R, Huverserian A, Feldman H, Thomasson A, Shults J, Hamano T, Shaked A,
    Olthoff, K, Rickels M, Goral S, Bleicher M, Leonard M.  End-stage liver disease is associated with
    extremely low levels of Vitamin D that improve markedly with liver transplantation.  Am J
    Transplantation 2010: 10 (Suppl 4): 175.
  33. Porrett PM, Ottmann S, Sonnad S, O’Donnell, Shaked A, Olthoff KM.  Pre-transplant ablative therapy
    does not provide survival benefit for patients outside of UCSF criteria.  Am J Transplantation 2010: 10
    (Suppl 4): 197.
  34. Olthoff KM, Friedman BH, Putt ME, Wang L, Shaked A, Christie JD, Hancock WW. Serum cytokine
    profiles associated with early allograft dysfunction following liver transplantation. Am J Transplantation
    2010: 10 (Suppl 4): 293.
  35. Reese P, Leonard M. Huverserian A, Thomasson A, Shults J, Shaked A, Olthoff K, Rickels M,
    Bleicher M, Feldman H, Hamano T, Goral S, Bloom R.  Vitamin D and new onset diabetes after liver
    transplantation. Am J Transplantation 2010: 10 (Suppl 4): 350.
  36. Melin A, Sonnad S, Porrett P, Conboy B, Olthoff KM.  Equivalent outcomes in patients over the age of
    65 compared to younger recipients following orthotopic liver transplant (OLT).  Am J Transplantation
    2010: 10 (Suppl 4): 360.
  37. Trotter F, Gillespie B, Terrault NA, Abecassis M, Merion r, Brown R, Olthoff KM, Hayashi PH, Berg CL, Fisher RA, Everhart JE and the Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Liver Transpl. 2011 April; 17:409-417.
  38. Hoteit M, Levine M, Sun W, Giantonio B, Reddy KR, Olthoff K, Shaked A. Patterns of recurrence of hepatocellular carcinoma after liver transplantation: Factors affecting survival. Am J Transplantation 2011 April; 104(Suppl 2):62.
  39. Porrett P, Cui R, Sonnad S, Ottmann S, Drazek D, Hoteit M, Olthoff K, Shaked A, Levine M. Impact of true MELD on post-transplant outcome in patients listed with exception MELD HCC points. Am J Transplantation 2011 April; 106(Suppl 2):63.
  40. Bonnell AR, Anderer K, Brandfass R, Abt PL, Olthoff KM, Shaked A. Long-term allograft function and pattern of injury following abrupt or gradual discontinuation of immunosuppression. Am J Transplantation 2011 April; 781(Suppl 2):264.
  41. Reese P, Leonard M, Olthoff K, Abt P, Huverserian A, Bleicher M, Shaked A, Goral S, Bloom R. Higher Vitamin D is associated with short-term acute rejection after liver transplantation. Am J Transplantation 2011 April; 782(Suppl 2):264.
  42. Mu Y, Abt PL, Levine MH, Olthoff KM, Shaked A. Consequences and pattern of injury following late acute cellular rejection in liver transplant recipients. AM  J Transplantation 2011 April: 784(Suppl 2):265.
  43. Wolf JH, Olthoff K, Abt P. Single Center outcomes for simultaneous thoracic and abdominal organ transplantation. Am J Transplantation 2011 April; 917(Suppl 2):301.
  44. Wolf JH, Wang L, Gillespie B, Baker T, Emond J, Christie J, Shaked A, Hancock W, Olthoff K. Hepatocyte growth factor levels correlate with degree of liver regeneration in living liver donors. Am J Transplantation 2011 April; 1038(Suppl 2):336.
  45. Porrett P, Cui R, Sonnad S, Ottmann S, Drazek D, Hoteit M, Olthoff K, Shaked A, Levine M. Prolonged wait list time does not negatively impact oncologic outcome in patients transplanted with HCC. Am J Transplantation 2011 April; 1492(Suppl 2):463.
  46. Mu Y, Abt PL, Levine MH, Porrett PM, Ottmann SE, Olthoff KM, Shaked A. Survival after tumor resection of HCC single metastases following liver transplantation. Am J Transplantation 2011 April; 1493 (Suppl 2):463.
  47. Levine MH, Fan E, Ottmann S, Drazek D, Bonnell A, Mu Y, Olthoff K, Shaked A, Furth E. Categorization of cirrhotomimetic growth patterns in explanted liver specimens and correlation with tumor recurrence and patient survival. Am J Transplantation 2011 April; 1494(Suppl 2):464.
  48. Levine MH, Sonnad S, Porrett P, Ottmann S, Cui R, Hoteit M, Rosen M, Siegelman E, Furth E, Olthoff K, Shaked A. The predictive value of Milan criteria for liver transplantation for hepatocellular carcinoma is derived from correlation with explant liver pathology. Am J Transplantation 2011 April; 1495(Suppl 2):464.
  49. Levine M, Porrett P, Cui R, Ottmann S, Hoteit M, Abt P, Furth E, Siegelman E, Rosen M, Olthoff K, Shaked A. Unexpected multicentricity in liver explants data from 358 consecutive liver transplants for HCC: Implication for resection of HCC in cirrhotic patients. Am J Transplantation 2011 April; 1496(Suppl 2):464.
  50. Sinha S, Levine M, Damjanov N, Reddy KR, Olthoff K, Shaked A, Hoteit M. Hepato-cholangiocarcinoma in liver transplantation: Frequency and outcomes. Am J Transplantation 2011 April; 1501(Suppl 2):466.
  51. Wolf JH, Wang L, Bhatti T, Han R, Hancock WW, Olthoff K. Use of Pan-Histone/Protein Deacetylase (HDAC) inhibitor reduces injury following hepatic ischemia-reperfusion. Am J Transplantation 2011 April; 1625(Suppl 2):504.
  52. Mu Y, Sonnad S, Abt PL, Levien MH, Olthoff KM, Shaked A. Late acute cellular rejection after liver transplantation: patterns of injury, chronic rejection and graft survival. Liver Transplantation 2012 May; 18:(5,Supp 1):S-104.
  53. 53. Wolf JH, Wang L, Shah R, Baker T, Emond J, Christie J, Shaked A, Hancock W, Olthoff K.
    Association between serum growth factor expression and liver regeneration in living donor liver
    transplantation. Liver Transplantation 2012 May; 18L5,Supp 1):S-155.
  54. 54.  Harbell, J., Fung, J., Nissen, N., Olthoff, K., Florman, S. S., Hanto, D. W., Light, J., Bartlett, S.
    T. , Tzakis, A. G. , Pearson, T. C. , Barin, B. , Roland, M.E. , Stock, P. G.,  Surgical Complications in
    275 HIV+ Liver and/or Kidney Transplant Recipients. Surgery, 2012 (In Press).
  55. 55.  Porrett P, Malik S, Cui R, Ottmann S, Drazek D, Hoteit M, Abt P, Shaked A, Olthoff K, Levine M;
    Increasing wait time does not adversely impact wait list or transplant outcomes in patients with HCC.
    Am J Transplant. 2012 May. 12(37):p. 1-586.
  56. 56.  Terrault NA, Stravitz RT, Lok AS, Everson GT, Brown, Jr RS, Kulik LB, Olthoff KM, Saab S,
    Rubinas T, Argo CK, Everhart JE, Rodrigo DR; Long-term Hepatitis C (HCV) graft loss and fibrosis
    severity is unrelated to donor type: results from the adult to adult living donor liver transplantation
    (A2ALL) study. Am J Transplant. 2012 May. 12(107): p. 1-586.
  57. 57.  Wolf JH, Stylianou I, Rader DJ, Shaked A, Olthoff K. Association of changes in serum lipoproteins
    and liver regeneration in living donor liver recipients. Am J Transplant. 2012 May. 12(107): p. 1-586.
  58. 58.  Olthoff KM, Stock PG, Liu J, Peng Y, Kim WR, Washburn WK, Harper AM, Edwards EB, Snyder
    JJ, Israni AK, Kasiske BL; High MELD/PELD versus status 1A: Who lives, who dies, and when?  
    Am J Transplant. 2012 May. 12(131): p. 1-586.
  59. Charak GS, Guzman AK, Abt PL, Goldberg DS, Levine MH, Olthoff KM, Shaked A; Early
    allograft dysfunction is not associated with graft failure in liver recipients of high donor risk index
    organs. Am J Transplant. 2012 May. 12(165): p. 1-586.
  60. Malik S, Sonnad S, Fayek S, Olthoff K, Abt P, Levine M, Shaked A; Donor and peri-operative
    variables impacting liver retransplantation outcomes. Am J Transplant. 2012 May. 12(259) p. 1-586.
  61. Enestvedt CK,  Malik S, Goldberg D, Porrett P, Levine M, Olthoff K, Shaked A, Abt P.  Predicting
    survival following liver retransplantation: Validation of a donor-derived scoring system. Am J
    Transplant. 2012 May. 12(429): p. 1-586.
  62. Wolf JH, Bhatti T, Hancock W, Shaked A, Olthoff K; Early growth factor expression and liver
    regeneration in living donor liver transplantation. Am J Transplant. 2012 May. 12(436): p. 1-586.
Editorials, Reviews, Chapters
  1. Millis JM, Olthoff KM, Imagawa DK, Baquerizo A, Busuttil RW.  Liver Transplantation at UCLA:  A Report of Clinical Activities. In:  Terasaki, PI, Ed.  Clinical Transplants 1988.  UCLA Tissue Typing Laboratory; Los Angeles. 1988.
  2. Olthoff KM, Brown SL, Busuttil RW.  Portal Hypertension.  In:  Moore WS, Ed.  Vascular Surgery:  A Comprehensive Review, Third Edition. W.B. Saunders Co.; Orlando.  1990.
  3. Olthoff KM and Busuttil RW.  Liver Transplantation in the Management of Portal Hypertension.  In:  Ernst CB and Stanley JC, Ed.  Current Therapy in Vascular Surgery, Third Edition.  Mosby-Year Book, Inc.; Philadelphia.  1995.
  4. Olthoff KM and Busuttil RW.  Venous Anomalies Including Portal Vein Thrombosis and Prior Portosystemic Shunts.  In:  Busuttil  RW and Klintmalm GB, Ed.  Transplantation of the Liver. Chapter 46: pp 46-47. W.B.Saunders; Philadelphia. 1996.
  5. Shaked A, Nunes FA, Olthoff KM, Lucey MR:  Assessment of liver function: Pre-and peri-transplant evaluation.  Clin Chem. 1997;43:1539-45.
  6. Weber M, Deng S, Olthoff K, Naji A, Barker CF, Shaked A, Brayman KL.  Organ transplantation in the twenty first century. Uro Clin North Am 1998;25(1):51-61.
  7. Zamir GA, Olthoff KM, Nunes FA, Markmann JF, Zeldin GA, Stewart CA, Weinreib RM, Rand EB, Maller ES, Lucey MR, Shaked A.  Liver Transplantation at the University of Pennsylvania and the Children's Hospital of Philadelphia.  In: Cecka and Terasaki, Ed.  Clinical Transplants, Chapter 20:pp 223-229, 1999.
  8. Nunes, FA, Olthoff KM, Lucey MR.  Liver Transplantation: Indications and Pretransplant Evaluation.  In: Bacon B and DiBisceglie, Ed.  A Diseases of the Liver, 1st Edition, Chapter 31: pp 383-391, 2000.
  9. Tarek R, Olthoff K, Reilly PM. Issues In Potential Organ Donor Management.  In:  Schwab CW, and Reilly PM, Guest Ed.  The Surgical Clinics of North America, 3rd Edition;80:1021-1032, 2000.
  10. Olthoff KM.  Cadaver Liver Donor Selection Criteria.  In: Norman and Turka, Ed. Primer on Transplantation, 2nd Edition, Chapter VII: pp 536-539, 2001.
  11. Zamir G, Olthoff KM, Shaked A, Gene therapy and graft modification.  Curr Opin Organ
    Transpl;6(4) 2001.
  12. Olthoff KM.  Can reperfusion injury of the liver be prevented?  Trying to improve on a good thing. Pediatric Transplantation 5:390-393 2001.
  13. Barker CF, Brayman KL, Markmann JF, Naji A, Olthoff KM, Shaked A.  Transplantation of Abdominal Organs.  In: Beauchamp, Evers, Mattox, Eds. Sabiston Textbook of Surgery, 16th Edition, Chapter 25: pp 429-470, 2001.
  14. Rand E, Olthoff KM.  Pediatric Liver Transplantation.  In:  Lucey M, Neuberger J, Shaked A, Eds.  Liver Transplantation, Chapter 10: pp 109-115, Landes Bioscience, 2002.
  15. Rand EB, Olthoff KM.  Overview of Pediatric Liver Transplantation.  David A Piccoli, MD, Guest Ed.  In:  Gastroenterol Clin N Am:  Pediatric Gastroenterology, Volume 32:913-929, 2003.
  16. Olthoff KM, Abt, PL, Shaked A.  Liver Transplantation.  K. Rajender Reddy, William B. Long Eds.  Requisites in Gastroenterology, Volume 3:243-255, 2004.
  17. Desai NM, Olthoff KM.  Portal Vein Thrombosis and Other Venous Anomalies in Liver Transplantation.  In:  Busuttil RW and Klintmalm GB. Eds.  Transplantation of the Liver, 2nd Edition 743-754, 2005.
  18. Olthoff K.  Liver Regeneration.  Clinical Relevance.  In:  Blumgart LH, DeMatteo RP, Eds.  Surgery of the Liver Biliary Tract and Pancreas, 4th Edition 54-62, 2006.
  19. Olthoff K, Markmann J. The Role of Re-transplantation.  Schiff ER, Sorrell MF, Maddrey WC, Eds. In: Schiff's Diseases of the Liver, 10th Edition 1546-1552, 2007.
  20. DeJonge J, Olthoff KM.  Liver Transplantation: Liver Regeneration.  Gruessner RWG, Benedetti E. Eds. In Living Donor Organ Transplantation 459-467, 2008.
  21. Markmann JF, Yeh H, Naji A, Olthoff KM, Shaked A, Barker C.  Transplantation of Abdominal Organs.  In: Townsend, Beauchamp, Evers, Mattox, Eds. Sabiston Textbook of Surgery, 18th Edition, Chapter 28: pp 692-733, 2008.
  22. Olthoff KM, Reddy KR. First, do no harm: The question of liver biopsy in living liver donors. Liver Transpl. 2008;14:420-422.
  23. Yeh H, Olthoff KM. Live donor adult liver transplantation. Current Opinion in Organ Transplantation. 2008:241-246.
  24. Porrett PM, Olthoff KM.  Hepatectomy. In: Gowned and Gloved Surgery: Introduction to Common Procedures.  Kanchwala S, Paulson EC, Roses R, Morris JM, Eds.  2008:102-113.
  25. Olthoff KM. Small size and disease severity in living donation: A difficult match. Liver Transpl. 2009:457-9.
  26. Olthoff KM, Forner A, Hubescher S, Fung J. What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation? Liver Transpl. 2011 Oct; 17 Suppl 2:S26-33.
  27. Washburn K, Olthoff K. Truth and consequences: the challenge of greater transparency in liver distribution and utilization. Am J Transplant. 2012 Apr; 12(4):808-9. doi: 10.1111/j.1600-6143.2011.03960.x. PMID: 22458382.
  28. Abt P, Olthoff K, The role of retransplantation. Schiff’s Diseases of the Liver, Eleventh Edition. Schiff E, Ed. 2012:1172-1182.
Books
  1. Fine, RN, Webber SA, Olthoff KM, Kelly DA, Harmon WE. eds., Pediatric Solid Organ Transplantation. 2nd Edition, Blackwell Publishing Ltd:2007.
Alternative Media
  1. Presenter in the Baylor CME Website for “The Molecular Surgeon” symposium
    www.baylorcme.org/onlinecme/molecsurg/pres_overview.html# (“Molecular Pathways of Injury and Repair in Liver Transplantation”
  2. Olthoff K: Lifetime TV Series: “Women Docs: A Critical Difference”, March 27, 2002.
  3. Editor/screenwriter for liver transplant educational videotape/DVD: A Living Donor Story, 2003.
  4. RNA Later vs All Protect Comparison    http://www.genetics.ucla.edu/transplant-genomics/files/RNALatervsAllProtectComparison.pdf
 
Awards, Honors and Membership in Honorary Societies
1978 - 1979 Freshman Honors Scholarship
 
1979 - 1982 Upperclassman Scholarship    
 
1981 - 1982 The Dr. Paul and Mrs. Doris Dirkse Health Care Scholarship
 
1986 - 1987 Outstanding First Year Resident
 
1997 - 1999 Orthobiotec/ASTS Faculty Development Award
 
1999 Physician of the Year - Delaware Valley Chapter of the American Liver Foundation
 
2001 The Carl Groth Lectureship in Transplantation Karolinska Institute, Stockholm, Sweden
 
2003 Roche/American Society of Transplant Surgeons Presidential Travel Award
 
2003 Fellow in Executive Leadership in Academic Medicine Program (ELAM), Drexel University
 
2004 Member of Working Group for Liver Transplantation
NIH Action Plan for Liver Disease Research
 
2004 Inaugural Thomas E. Starzl State of the Art Lectureship, Boston, MA
 
2007 The First Olga Jonasson Lecture, Division of Transplantation
University of Illinois at Chicago
 
2012 - 2013 President, American Society of Transplant Surgeons
 
2013 - 2015 Provost’s Penn Fellows Program

Dr. Kim Olthoff

 
footer Terms of Use Legal Disclaimer Site Map Contact Us Financial Assistance About Penn Medicine Privacy Statement
penn medicine